Many medical conditions, treatments and treatment responses are particular to children or differ from their adult equivalents.1,2 Also, many potentially useful treatments are unlicensed for children. In general practice, at least 1 in 10 medicines prescribed for children are unlicensed or are used 'off-label'.3 These circumstances make the launch of the BNF for Children (BNFC) in September 2005 an important development. We review this new publication.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.